Treatment with a diphtheria toxin-related interleukin 2 fusion protein prolongs cardiac allograft survival in mice.
Barrett
L V
LV
Brigham and Women's Hospital, Boston, MA 02115.
Murphy
J R
JR
Strom
T B
TB
Kirkman
R L
RL
D000818:Animals; D004167:Diphtheria Toxin / Q000627:therapeutic use*; D006085:Graft Survival / Q000187:drug effects*; D016027:Heart Transplantation; D007376:Interleukin-2 / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008815:Mice, Inbred Strains; D009154:Mutation; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use*; D014184:Transplantation, Homologous
D004167:Diphtheria Toxin; D007376:Interleukin-2; D011993:Recombinant Fusion Proteins; D011994:Recombinant Proteins